Petros Pharmaceuticals, Inc. (PTPI)
NASDAQ: PTPI · IEX Real-Time Price · USD
0.426
-0.027 (-6.05%)
At close: Jul 16, 2024, 4:00 PM
0.403
-0.022 (-5.26%)
Pre-market: Jul 17, 2024, 5:59 AM EDT

Petros Pharmaceuticals Revenue

Petros Pharmaceuticals had revenue of $4.69M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $1.39M. In the year 2023, Petros Pharmaceuticals had annual revenue of $5.82M.

Revenue (ttm)
$4.69M
Revenue Growth
-22.36%
P/S Ratio
0.63
Revenue / Employee
$223,487
Employees
21
Market Cap
2.98M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20235.82M-169.67K-2.83%
Dec 31, 20225.99M-1.82M-23.29%
Dec 31, 20217.81M-1.75M-18.29%
Dec 31, 20209.56M-6.02M-38.63%
Dec 31, 201915.58M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Healthcare Triangle 27.47M
INVO Bioscience 4.25M
60 Degrees Pharmaceuticals 569.86K
Exicure 500.00K
FOXO Technologies 139.00K
Revenue Rankings